DBVT DBV Technologies S.A. ADRs

DBV Technologies SA is a biopharmaceutical company. It is engaged in research and development of patient-friendly therapy for food and pediatric allergy patients. This is an ADR of a company whose stock trades outside of the U.S. as the symbol FP:DBV.

$1.60  +0.02 (1.27%)
As of 03/27/2023 11:07:54 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  ADRs
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  France
Country of incorporation:  France
IPO date:  10/22/2014
Outstanding shares:  188,274,290
Average volume:  27,866
Market cap:   $303,121,607
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BRS66Y4

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%